register-based study
Showing 9976 - 10000 of >10,000
HIV Vaccine Trial in São Paulo (Alpha-type-1 Polarizing Dendritic Cells (aDC1) unpulsed with HIV peptides, Alpha-type-1
Not yet recruiting
- HIV Vaccine
- Alpha-type-1 Polarizing Dendritic Cells (aDC1) unpulsed with HIV peptides
- +2 more
-
São Paulo, BrazilHospital das Clínicas da Faculdade de Medicina da USP
Mar 14, 2023
Post Traumatic Stress Disorder Trial in Menlo Park, San Antonio, Toronto (Quality Improvement Learning Community,
Recruiting
- Post Traumatic Stress Disorder
- Quality Improvement Learning Community
- Fidelity-oriented Learning Community
-
Menlo Park, California
- +2 more
Sep 14, 2021
Pain, Chronic, Widespread Chronic Pain Trial in Lidköping, Uddevalla (Internet-based cognitive behavioral therapy +
Recruiting
- Pain, Chronic
- Widespread Chronic Pain
- Internet-based cognitive behavioral therapy + physiotherapy
- Physiotherapy only
-
Lidköping, Sweden
- +1 more
Sep 23, 2022
Hemiplegia, Gait, Hemiplegic, Motor Function Trial in Istanbul (Exercise Therapy, Exercise Therapy and Robotic Walking Training)
Recruiting
- Hemiplegia
- +3 more
- Exercise Therapy
- Exercise Therapy and Robotic Walking Training
-
Istanbul, TurkeyIstanbul Medipol University
Aug 10, 2022
Neuromuscular Diseases Trial in Garches (Objective adjustment of the MI/E exsuflation pressure and evaluation of cough effort,
Active, not recruiting
- Neuromuscular Diseases
- Objective adjustment of the MI/E exsuflation pressure and evaluation of cough effort
- Subjective adjustment of the MI/E exsuflation pressure and evaluation of cough effort
-
Garches, Hauts-de-Seine, FranceDepartment of Physiology and Functional Explorations, Raymond Po
Aug 11, 2022
Sudden Infant Death Trial in Rapid City (Protecting Babies While they Sleep Curriculum)
Completed
- Sudden Infant Death
- Protecting Babies While they Sleep Curriculum
-
Rapid City, South DakotaAvera Research Institute
Aug 10, 2022
IgA Nephropathy at High Risk of Developing ESRD Trial in Beijing (The Yi-Qi-Qing-Jie herbal compound, Immunosuppressants,
Recruiting
- IgA Nephropathy at High Risk of Developing ESRD
- The Yi-Qi-Qing-Jie herbal compound
- +3 more
-
Beijing, Beijing, ChinaGuang anmen Hospital, China Academy of Chinese Medical Sciences
Mar 15, 2022
Anemia Trial in United States (INTERCEPT, Control)
Recruiting
- Anemia
- INTERCEPT
- Control
-
Los Angeles, California
- +15 more
Mar 2, 2022
Hip Displacement in Children With Cerebral Palsy in Denmark
Enrolling by invitation
- Child
- +5 more
- Radiographic examination with a Migration of > 40 %
-
Hvidovre, Region Hovedstaden, DenmarkFysio- og Ergoterapien, afsnit 234-236, Hvidovre hospital
Jul 28, 2020
DLBCL, DLBCL Germinal Center B-Cell Type, DLBCL, Not Otherwise Specified Trial in Columbus (Molecular Nanotechnology)
Recruiting
- Diffuse Large B-Cell Lymphoma
- +3 more
- Molecular Nanotechnology
-
Columbus, OhioOhio State University Comprehensive Cancer Center
Jun 2, 2022
Nasopharyngeal Carriage of Children and Adolescents Based on
Recruiting
- Pneumonia
- NP/OP swab
-
Baisha, Hainan, China
- +4 more
Jun 24, 2023
Nanoliposomal Irinotecan With Fluorouracil and Folinic Acid in
Not yet recruiting
- Pancreatic Adenocarcinoma Metastatic
-
Pessac, FranceCHU Bordeaux
Aug 17, 2023
Cancer Trial in Nijmegen (Buddy)
Recruiting
- Cancer
- Buddy
-
Nijmegen, Gelderland, NetherlandsRadboudumc
May 9, 2022
Retinal Pigment Epithelium Detachment in Neovascular Age-related
Active, not recruiting
- Neovascular Age-related Macular Degeneration
- Anti-vascular endothelial growth factor therapy
-
Krasnodar, Russian FederationThe S.N. Fyodorov Eye Microsurgery State Institution
Jan 12, 2022
Diabetes Trial in Nashville (Diabetes Care Gaps Patient Portal Intervention)
Recruiting
- Diabetes Mellitus
- Diabetes Care Gaps Patient Portal Intervention
-
Nashville, TennesseeVanderbilt University Medical Center
May 1, 2022
Mobility Limitation, Spinal Fusion, Acute Pain Trial in Palo Alto, Stanford (Virtual Reality/Augmented Reality Headset)
Enrolling by invitation
- Mobility Limitation
- +2 more
- Virtual Reality/Augmented Reality Headset
-
Palo Alto, California
- +1 more
May 3, 2022
Heart Diseases, Ischemic, Coronary Artery Disease, Coronary Arteriosclerosis Trial in Ajman (Power walking, Standardised
Completed
- Heart Diseases, Ischemic
- +4 more
- Power walking
- Standardised outpatient cardiac rehabilitation
-
Ajman, United Arab EmiratesGulf Medical University
Oct 16, 2022
Liver Failure Trial in China (ALF, SALF, ACLF)
Recruiting
- Liver Failure
- ALF
- +2 more
-
Xi'an, Shaanxi, China
- +13 more
Feb 22, 2023
Breast Feeding, Separation, Family Trial in Gaziantep (Giving breastfeeding training)
Recruiting
- Breast Feeding
- Separation, Family
- Giving breastfeeding training
-
Gaziantep, TurkeyHasan Kalyoncu University
Feb 21, 2023
Self Efficacy, Breast Feeding, Attachment Trial in Famagusta (My Breastfeeding Guide)
Recruiting
- Self Efficacy
- +2 more
- My Breastfeeding Guide
-
Famagusta, CyprusEastern Mediterranean University
Jun 12, 2023
Substance-Related Disorders, Opioid-Related Disorders Trial in Indianapolis (Data-Driven Decision Making (DDDM),
Enrolling by invitation
- Substance-Related Disorders
- Opioid-Related Disorders
- Data-Driven Decision Making (DDDM)
- Overdose-prevention strategies inventory
-
Indianapolis, IndianaIndiana University School of Medicine
Oct 10, 2023
Bulimia Nervosa Trial in Heidelberg (Selfapy for Bulimia Nervosa)
Recruiting
- Bulimia Nervosa
- Selfapy for Bulimia Nervosa
-
Heidelberg, Baden-Württemberg, GermanyHeidelberg University
May 16, 2022
Epilepsy, Anxiety Disorders Trial in Toronto (HMD: Virtual Reality Exposure Therapy, HMD: Neutral Game)
Not yet recruiting
- Epilepsy
- Anxiety Disorders
- HMD: Virtual Reality Exposure Therapy
- HMD: Neutral Game
-
Toronto, Ontario, CanadaToronto Western Hospital
Aug 31, 2023
Sedentary Lifestyle Trial (Start to stand, generic advice)
Completed
- Sedentary Lifestyle
- Start to stand
- generic advice
- (no location specified)
Dec 3, 2021
Fall Trial (Otago Exercise Program)
Recruiting
- Fall
- Otago Exercise Program
-
Zuni Pueblo, New MexicoZuni Health Initiative
Nov 1, 2022